gms | German Medical Science

G-I-N Conference 2012

Guidelines International Network

22.08 - 25.08.2012, Berlin

Process and methods for reviewing NICE clinical practice guidelines

Meeting Abstract

  • T. Tan - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom
  • E. McFarlane - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom
  • K. Harrison - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom
  • F. Siddiqui - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom
  • K. Ashfaq - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom
  • A. McGill - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom
  • S. Willett - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom
  • L. Millward - National Institute for Health and Clinial Excellence (NICE), Manchester, United Kingdom

Guidelines International Network. G-I-N Conference 2012. Berlin, 22.-25.08.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. DocO71

DOI: 10.3205/12gin103, URN: urn:nbn:de:0183-12gin1035

Veröffentlicht: 10. Juli 2012

© 2012 Tan et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Background: Over 135 clinical practice guidelines have been published by the UK National Institute for Health and Clinical Excellence (NICE) since 2002. These guidelines need to be reviewed and updated periodically due to new evidence arises or change of current practice, to ensure they remain credible summaries of current best practice.

Context: Currently, NICE has a policy of reviewing its guidelines three years after publication. New process and methods for reviewing guidelines were developed in 2010 and evaluated in 2011. The evaluation process is still ongoing to ensure maximal accuracy and efficiency.

Description of best practice: Briefly, there are three stages of the NICE new process and methods as follow:

Stage one: Initial intelligence gathering (scoping search, high-level RCT search, survey from the original guideline development group, collation of post-publication queries and implementation feedback).

Stage two: Based on Stage one, conduct detailed focus searches on specific clinical areas using PICOs; Summarise all identified new evidence and intelligence, with a proposed review decision on the need to update.

Stage three: Public stakeholder consultation; Modify proposed review decision based on stakeholder comments; Further verification of the proposed review decision by NICE Guidance Executive and publish final review decision

Lessons for guideline developers, adaptors, implementers, and/or users: To date, 48 review decisions have been published. Using Stage three as a verifier, the accuracy of proposed review decisions (based on Stage one and two) is 91%. Further evaluation is warranted to improve efficiency.